Your browser doesn't support javascript.
loading
Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing.
Li, Jing; Li, Jingjing; Dai, Shuzhi; Dang, Li; Wang, Lin; Cao, Ling; Chen, Xiaobo; Wang, Ying; Ge, Menglei; Liu, Weijie; Song, Qinwei; Xu, Wenjian; Ma, Lijuan.
Afiliación
  • Li J; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Li J; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Dai S; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Dang L; Department of Outpatient Treatment Center, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Wang L; Department of Child Health Care, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Cao L; Department of Respiratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Chen X; Department of Endocrinology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Wang Y; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Ge M; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Liu W; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Song Q; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Xu W; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
  • Ma L; Department of Clinical Laboratory, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.
Front Immunol ; 14: 1269665, 2023.
Article en En | MEDLINE | ID: mdl-37828994

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / COVID-19 País/Región como asunto: Asia Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / COVID-19 País/Región como asunto: Asia Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article